Private law

Renesas and Dialog Semiconductor Announce Conclusion of Final Regulatory Review and the Expected Closing Date for Renesas’ Proposed Acquisition of Dialog Semiconductor

Retrieved on: 
Monday, August 16, 2021
Semiconductor, Hardware, General Automotive, Technology, Automotive, Battery management system, Court, Forward-looking statement, TSE, Renesas Electronics, Industry, FWB, Computer configuration, Perception, Dialog Semiconductor, Environment, BLE, Uncertainty, JST, Registrar of Companies, YouTube, LinkedIn, ICS, Private law, ISIN, Lightwave Electronics Corporation, Twitter, R, An Absolutely Remarkable Thing, Risk, Nature, Regulated market, Acquisition, Marketing, SOC, Review, XETRA, Efficiency, Scheme, Wi-Fi, Internet, Bluetooth, IOT, Solution, Dialogue, Cryptocurrency, Video game console, Audit, Risk management, Renesas Electronics Corporation, Dialog Semiconductor plc, RENESAS ELECTRONICS CORPORATION, DIALOG SEMICONDUCTOR PLC

Renesas does not intend to implement significant changes to its organization at the time of the closing of the acquisition.

Key Points: 
  • Renesas does not intend to implement significant changes to its organization at the time of the closing of the acquisition.
  • A further announcement will be made upon August 30, 2021 (London time), August 31, 2021 (JST) when the acquisition is complete.
  • Dialog Semiconductor plc ( XETRA:DLG ) (Dialog Semiconductor) is a leading provider of standard and custom integrated circuits (ICs) that power the Internet of Things and Industry 4.0 applications.
  • (Remarks) Dialog and the Dialog logo are trademarks of Dialog Semiconductor Plc or its subsidiaries.

Allen Matkins Welcomes Commercial Litigation and White Collar Criminal Defense Partner Kevin D. Lloyd

Retrieved on: 
Monday, August 16, 2021
Professional Services, Other Construction & Property, Legal, Commercial Building & Real Estate, Finance, Construction & Property, Mattel, Intellectual property, Private law, CEO, Bankruptcy, Allen Matkins, SEC, Natural Resources, Employment, Risk management, Duke University, Public Citizen Litigation Group, Stanford Law School, Property management

Allen Matkins , a California-based, full-service business and real estate law firm, announced today the addition of litigation partner Kevin D. Lloyd to its Los Angeles office.

Key Points: 
  • Allen Matkins , a California-based, full-service business and real estate law firm, announced today the addition of litigation partner Kevin D. Lloyd to its Los Angeles office.
  • Kevins vast experience in commercial litigation, having represented clients on a broad spectrum of complex and high profile matters, makes him a valuable addition to our dynamic litigation team, says Allen Matkins partner Anthony J. Oliva , head of the firms Litigation Group.
  • His white collar criminal defense experience is yet another highlight of his practice that will expand the capacity of our litigation department.
  • Kevin looks forward to joining the Allen Matkins litigation team and to working with the firms real estate and corporate practices to provide comprehensive legal services to the firms clients.

Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial Results and Provides General Business Update

Retrieved on: 
Thursday, August 12, 2021
Regulation of tobacco by the U.S. Food and Drug Administration, PRO, Forward-looking statement, U.S. Securities and Exchange Commission, CMC, Regulation, Fast Track, DMC, Private law, COVID-19, Company, Catheter, Data monitoring committee, Food, Patent, Securities Act of 1933, IND, Potency (pharmacology), CGMP, SEC, Research, NDA, FDA, Annual report, Security (finance), Drug Quality and Security Act, Patient, Mouse, Exercise, Mino, G&A, Securities Exchange Act of 1934, Acute respiratory distress syndrome, Quality of life, Article, Hospital, Pharmaceutical industry, Medical device, Lithium

Consequently, we expect recruitment for our Mino-Lok trial will be slower in the near term than we had originally planned.

Key Points: 
  • Consequently, we expect recruitment for our Mino-Lok trial will be slower in the near term than we had originally planned.
  • We look forward to updating you on these efforts in due course," stated Myron Holubiak, President and Chief Executive Officer of Citius Pharmaceuticals.
  • Third Fiscal Quarter 2021 Financial Results:
    As of June 30, 2021, the Company had $115.7 million in cash and cash equivalents.
  • In January 2021, the Company closed a private placement for common stock and warrants totaling gross proceeds of approximately $20 million.

Expanded Leadership Team Bolsters Ulmer's Growing Health Care Practice

Retrieved on: 
Thursday, August 12, 2021
Multimedia, Private law, Seiler, Compliance, Acquisition, Ulmer, Organization, Long-term care, Growth, Fraud, Nursing, Knowledge, Industry, Hospital, Health care, Medicine

This substantial body of transactional work and marked growth in talent inspired Ulmer to expand the Health Care Practice Group's leadership in order to build on the practice's continued success and growing client demand.

Key Points: 
  • This substantial body of transactional work and marked growth in talent inspired Ulmer to expand the Health Care Practice Group's leadership in order to build on the practice's continued success and growing client demand.
  • "Our health care practice is second to none, and this enhanced leadership team better reflects our position as a major player in the health care sector," said Scott P. Kadish, Managing Partner.
  • Adams has served as a leader of the Health Care Practice Group since 2015, focusing her legal practice on a range of interconnected legal disciplines including health care, mergers and acquisitions, and a variety of corporate law matters.
  • The Health Care Practice Group offers clients full-service capabilities, helping them achieve their overarching business objectives while navigating important regulatory requirements under state and federal law.

"Phone-Book" Annual Sustainability Reports Need to be Replaced with Focused, Data-Driven Communication Tailored for Stakeholders

Retrieved on: 
Thursday, August 12, 2021
Time, Multimedia, The Conference Board, Private law, Environment, Disclosure, ESG, Goal, CSR, Research, Language, Company, Organization, Conference, Risk management, Weil, Gotshal & Manges, Tax, Rest, Lawyer, Face, Industry, Database, Corporation, Public relations, Entertainment, Marketing, Lithium, Audit

Such reports can serve as central repositories of information, but companies need a more tailored approach to address the key stakeholders, says a new study by The Conference Board ESG Center.

Key Points: 
  • Such reports can serve as central repositories of information, but companies need a more tailored approach to address the key stakeholders, says a new study by The Conference Board ESG Center.
  • The research examines how companies can tell their sustainability story more effectively, authentically, and reliably to multiple audiences.
  • Companies are facing a looming tsunami of often highly detailed information requests from their business partners on environmental and social topics.
  • Neglecting or downplaying negative sustainability information risks companies' credibility with their stakeholders, and may make them susceptible to investor accusations of greenwashing.

MN Custom Homes Donates Proceeds to Jubilee REACH

Retrieved on: 
Thursday, August 12, 2021
Time, Housing, Puget Sound region, Heart, SE, Private law, COVID, Pacific Northwest, School, Family, Sale, McFadden, Student, Clothing, ESL, Life, Tree, Hospital

Jubilee will turn those funds into game-changing assistance for local families, and students who normally struggle to make ends meet.

Key Points: 
  • Jubilee will turn those funds into game-changing assistance for local families, and students who normally struggle to make ends meet.
  • In addition to this financial gift to Jubilee, MN Custom Home's entire staff and many subcontractors volunteer their time during Jubilee's annual Service Days, refurbishing tired homes for the elderly or disabled.
  • Founded in 2011 by Bellevue natives McFadden and Joe Naeseth,MN Custom Homes is celebrating its 10th anniversary this year.
  • MN Custom Homes builds luxury, single family residences among Greater Seattle's Eastsidecommunities.

Barnwell Fiscal Q3 Revenue Increases 28% in the quarterly period to $5.1 Million, Reports Net Earnings of $5.0 Million and $0.59 Net EPS; Regains Compliance with NYSE

Retrieved on: 
Wednesday, August 11, 2021
NYSE American, Income, Company, Barnwell, Private Securities Litigation Reform Act, U.S. Securities and Exchange Commission, Private law, Security (finance), Program, Securities Exchange Act of 1934, NYSE, Forward-looking statement, Annual report, Sale, Phrase, Form 10-K, Compliance, Securities Act of 1933, Tax, Joint venture, Anadarko Basin, GLOBE, Bank, Life insurance

Additionally, in the current quarter the Company recognized a $2,341,000 gain on termination of its post-retirement medical plan.

Key Points: 
  • Additionally, in the current quarter the Company recognized a $2,341,000 gain on termination of its post-retirement medical plan.
  • Also, the Companys sale of our Hawaii corporate office is scheduled to close for $2,000,000 in our fourth quarter of fiscal 2021.
  • These statements include various estimates, forecasts, projections of Barnwells future performance, statements of Barnwells plans and objectives, and other similar statements.
  • Forward-looking statements involve risks, uncertainties and assumptions which could cause actual results to differ materially from those contained in such statements.

Womble Bond Dickinson UK partners with Everlaw to further control of flexible, fast legal review process

Retrieved on: 
Wednesday, August 11, 2021
Adoption, CEO, WBD, Lawyer, Wealth, Association, Natural Resources, Efficiency, Corporation, Menlo Ventures, Employment, Private law, Review, Partnership, United States Senate Finance Subcommittee on Energy, Natural Resources, and Infrastructure, COVID-19, Time, CapitalG, Lex Mundi, Technology, List of life sciences, Consumer, Real estate, Financial institution, Womble Bond Dickinson, Biotechnology, Founder, IP, AM, LLP, Construction, Property management

OAKLAND, Calif., Aug. 11, 2021 /PRNewswire/ --Law firm Womble Bond Dickinson (UK) LLP (WBD UK) announced today a partnership with Everlaw to provide its legal teams with enhanced flexibility and control throughout the legal review process.

Key Points: 
  • OAKLAND, Calif., Aug. 11, 2021 /PRNewswire/ --Law firm Womble Bond Dickinson (UK) LLP (WBD UK) announced today a partnership with Everlaw to provide its legal teams with enhanced flexibility and control throughout the legal review process.
  • The firm's legal teams needed a powerful solution to remotely and securely review and analyse documents.
  • WBD UK found Everlaw best suited its needs for ease of use and costs.
  • "You can't offer first-class legal advice without first-class technology," said Amy Prime, associate at WBD UK.

Womble Bond Dickinson UK partners with Everlaw to further control of flexible, fast legal review process

Retrieved on: 
Wednesday, August 11, 2021
Adoption, CEO, WBD, Lawyer, Wealth, Association, Natural Resources, Efficiency, Corporation, Menlo Ventures, Employment, Private law, Review, Partnership, United States Senate Finance Subcommittee on Energy, Natural Resources, and Infrastructure, COVID-19, Time, CapitalG, Lex Mundi, Technology, List of life sciences, Consumer, Real estate, Financial institution, Womble Bond Dickinson, Biotechnology, Founder, IP, AM, LLP, Construction, Property management

OAKLAND, Calif., Aug. 11, 2021 /PRNewswire/ -- Law firm Womble Bond Dickinson (UK) LLP (WBD UK) announced today a partnership with Everlaw to provide its legal teams with enhanced flexibility and control throughout the legal review process. Everlaw's cloud-based ediscovery platform lets users organise, review and analyse large amounts of data and collaborate in one central place, from anywhere, which has created more efficiency for lawyers during a time when clients are more conscious than ever about value for their money.

Key Points: 
  • OAKLAND, Calif., Aug. 11, 2021 /PRNewswire/ --Law firm Womble Bond Dickinson (UK) LLP (WBD UK) announced today a partnership with Everlaw to provide its legal teams with enhanced flexibility and control throughout the legal review process.
  • The firm's legal teams needed a powerful solution to remotely and securely review and analyse documents.
  • WBD UK found Everlaw best suited its needs for ease of use and costs.
  • "You can't offer first-class legal advice without first-class technology," said Amy Prime, associate at WBD UK.

Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Retrieved on: 
Tuesday, August 10, 2021
Science, Other Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Clinical Trials, Lupus, Industry, CD28, Oncology, Achievement, American Society of Clinical Oncology, AbbVie, Safety, Nature, LinkedIn, Patient, ASCO, EULAR, Exercise, ALPN, Private Securities Litigation Reform Act, U.S. Securities and Exchange Commission, Protein engineering, Private law, Technology, Security (finance), Securities Exchange Act of 1934, Cancer, Forward-looking statement, Clinical research, European Alliance, Immunology, Pembrolizumab, COVID-19, Research, Twitter, Annual general meeting, Society, Securities Act of 1933, Population, NASDAQ, Investment, Iovance Biotherapeutics, Webcast, Drug Quality and Security Act, Growth, Pharmaceutical industry, Health insurance, Vaccine

Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today provided a corporate update and reported financial results for the second quarter ended June 30, 2021.

Key Points: 
  • Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today provided a corporate update and reported financial results for the second quarter ended June 30, 2021.
  • Alpine will host a conference call and live webcast to discuss the second quarter performance today, August 10, 2021 at 4:30 p.m. ET/1:30 p.m. PT.
  • Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics.
  • SIP and TIP, and the Alpine logo are registered trademarks or trademarks of Alpine Immune Sciences, Inc. in various jurisdictions.